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Abstract
Genome packaging for viruses with segmented genomes is often a complex problem. This is particularly true for influenza
viruses and other orthomyxoviruses, whose genome consists of multiple negative-sense RNAs encapsidated as
ribonucleoprotein (RNP) complexes. To better understand the structural features of orthomyxovirus RNPs that allow them
to be packaged, we determined the crystal structure of the nucleoprotein (NP) of a fish orthomyxovirus, the infectious
salmon anemia virus (ISAV) (genus Isavirus). As the major protein component of the RNPs, ISAV-NP possesses a bi-lobular
structure similar to the influenza virus NP. Because both RNA-free and RNA-bound ISAV NP forms stable dimers in solution,
we were able to measure the NP RNA binding affinity as well as the stoichiometry using recombinant proteins and synthetic
oligos. Our RNA binding analysis revealed that each ISAV-NP binds ,12 nts of RNA, shorter than the 24–28 nts originally
estimated for the influenza A virus NP based on population average. The 12-nt stoichiometry was further confirmed by
results from electron microscopy and dynamic light scattering. Considering that RNPs of ISAV and the influenza viruses have
similar morphologies and dimensions, our findings suggest that NP-free RNA may exist on orthomyxovirus RNPs, and
selective RNP packaging may be accomplished through direct RNA-RNA interactions.
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Introduction
Influenza viruses represent a serious public health concern due
to their potential in causing widespread epidemics and pandemics.
The genomes of the influenza A and B viruses are both comprised
of eight segments of negative-sense RNA [1]. These eight gene
segments are encapsidated in the form of rod-shaped, double-
helical ribonucleoprotein (RNP) complexes in virions as well as in
infected cells [2]. Each RNP contains a viral RNA, a heterotri-
meric viral polymerase (consisting of PA, PB1, and PB2) and
multiple copies of the viral-encoded nucleoprotein (NP) that bind
viral RNA in a stoichiometric manner.
The segmented genome of influenza viruses offers a number of
replication advantages such as gene recombination and transcrip-
tional regulation, but at the same time it creates challenges for
genome packaging. Once controversial, it is now widely accepted
that the vRNPs of the influenza A viruses are specifically packaged
into the virion, so that each particle contains eight unique
segments of viral RNA (vRNA). Early evidence from defective-
interfering RNAs (DI RNAs) and reverse genetics [3,4] indicated
that each gene segment possesses distinct packaging signals, and
that unique sequences from both non-coding and coding regions at
the 59 and 39 ends of all eight vRNA segments are essential for
vRNA packaging [5–9]. Electron microscopy and tomography
images showed that vRNPs in budding virions were organized in a
distinct ‘‘7+1’’ pattern, with a long segment in the center
surrounded by seven segments of various lengths at the periphery
[10–13]. During virus assembly, vRNPs are aligned at the budding
tip and interconnect with each other to form a supra-molecular
assembly. Fluorescence in situ hybridization (FISH) analysis of
single virus particles further confirmed that the eight unique RNPs
are selectively incorporated into progeny virions and most virus
particles contain only one copy of each of the eight RNP
complexes [14].
Early electron microscopy studies of isolated influenza A virus
RNPs revealed rod-shaped structures with a double-helical
arrangement [15,16]. Recently, cryo-EM reconstructions of the
influenza A virus RNP have been calculated to ,20 A˚ resolution
[17,18]. The double-helical stem region of the RNP shows a rise
between two neighboring NP of ,30 A˚ with five to six NP
molecules per turn. Interaction between the two opposing arms of
an RNP hairpin is solely mediated by the NP. Adjacent NP
molecules on the same RNA strand interact through the extended
NP tail loop. The putative RNA binding groove of the NP scaffold
is exposed on the outer surface of the RNP.
Previous studies based on genome-wide stoichiometry calcula-
tions showed that there are ,24–28 nts of RNA for each NP
molecule [15,19,20]. In the absence of NP, vRNAs are able to
mediate a comprehensive interaction network, with each vRNA
segment interacting with at least one other vRNA partner,
suggesting that RNPs are likely held together by direct base-
pairings between packaging signals [12]. This model raises an
intriguing question as to how the packaging signals are presented
on the surface of the RNPs. Is vRNA maintained in an extended
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configuration devoid of any secondary structure by tight wrapping
around the NP, or perhaps some NP-free RNAs exist in the RNP
to allow vRNA-vRNA interaction?
To better understand the mechanism of influenza virus RNP
packaging, we performed a series of structural and functional
studies of the NP from the infectious salmon anemia virus (ISAV).
ISAV is the first orthomyxovirus isolated from fish, and it (genus:
Isavirus) is capable of causing wide-spread, severe anemia in
Atlantic salmon and other salmonid species [21,22]. Although
their gene sequences are highly divergent, ISAV and influenza
viruses share many similarities in their genomic, structural,
morphological, and physiochemical properties. Here we deter-
mined the first crystal structure of an ISAV NP to 2.7 A˚ resolution.
The crystal structure of ISAV-NP shows a head and a body
domain that resemble those of the influenza A virus NP, despite
the lack of sequence similarity. Using fluorescence anisotropy
assays with synthetic RNA oligos, we showed that each ISAV-NP
molecule binds to 12 nts of RNA, much shorter than the 24 nts
originally estimated by genome-wide calculation for the related
influenza A virus [15,19,20]. The 12-nt RNA binding stoichiom-
etry is further supported by results obtained by electron
microscopy and dynamic light scattering, as the addition of a
48-nt RNA to a solution of ISAV-NP led to the formation of NP
tetramers or the dimerization of NP dimers. Our results thus
suggest that a considerable amount of genomic RNA may exist in
a NP-free state within the orthomyxovirus RNPs, and this free
RNA may mediate the formation of high-order structures
necessary for the specific recognition of the eight individual RNPs
during virus assembly.
Results and Discussion
ISAV-NP forms stable dimers in solution
ISAV-NP was overexpressed in E. coli and purified as dimers
with an approximate molecular weight of 140 kD, as estimated
from the gel filtration chromatogram (Fig. 1). The ISAV-NP dimer
was stable and did not dissociate under a wide range of conditions
when tested in vitro (e.g. 0.01 to 10 mg/mL protein, NaCl ranging
from 0.05 to 1 M, at 4 or 25uC for up to one month, etc). These
unusual features of ISAV-NP make it an excellent system for
studying NP RNA binding properties for the orthomyxoviruses, as
the recombinant NPs of both influenza A and B viruses are known
to form multiple oligomeric species [23–25]. Furthermore,
influenza A virus NP oligomers and monomers undergo dynamic
equilibrium in solution [23], and the addition of short RNA oligos
led to the formation of larger oligomers possibly due to quaternary
structure re-arrangement [24,26]. RNPs from ISAV and influenza
viruses exhibit similar double-helical morphologies in EM
[15,17,18,27].
Crystal structure of ISAV-NP
Crystals of the full-length ISAV-NP were obtained, which only
diffracted to ,10 A˚ resolution. A number of N-terminal
truncation mutants, including DN39, DN50, DN64, and DN84,
and DN111, were subsequently cloned and expressed. Although
DN50, DN64, and DN84 produced crystals, their diffraction was
also poor. Visual inspection of the ISAV-NP sequence revealed a
highly acidic C-terminal tail (i.e. 600EIEFDEDDEEEEDIDI616,
with 12 out of the last 16 residues being either Glu or Asp); a
feature that has been previously noted in many orthomyxovirus
NPs. Without the last 16 residues, the ISAV-NP DC16 mutant also
formed dimers, similar to the full-length protein (Fig. 1), and
produced crystals that diffracted far better up to 2.7 A˚ resolution.
The slight increase in the elution volume of the ISAV-NP DC16
mutant in gel filtration chromatography is likely due to changes in
NP’s radius of gyration or differences in protein-resin interaction.
The crystal structure of the ISAV-NP DC16 was determined by
single-wavelength anomalous dispersion (SAD). The final model
contains 495 amino acid residues in total, including residues 5–25,
27–38, 41–45, 61–75, 86–112, 133–182, 201–320, 325–497, 504–
530, and 542–586. Each NP molecule can be divided into three
domains: an N-terminal domain, a head domain, and a body
domain (Fig. 2A). While the N-terminal domain is made up of a
single polypeptide stretch containing the first 111 residues, the
head and body domains are not colinear, with the head domain
made from two excursions of the polypeptide chain (residues 272–
380 and 494–558) out of the body domain. Structural comparison
shows that the head and body domains of ISAV-NP closely
resemble those of the influenza A virus NP, despite the lack of
significant sequence similarity (Figure 2B, E).
Although there is only one NP in each crystallographic
asymmetric unit, dimers are found around the crystallographic
two-fold symmetry axes (Fig. 2A), which are presumably the same
as those found in the solution (Fig. 1). The tail loop structure,
which plays a critical role in influenza A virus NP oligomerization,
is also found in ISAV-NP, although these two NP proteins form
oligomers of different sizes (dimer vs. trimer). The tail loop of
ISAV-NP (residues 504–530) folds into an extended b-hairpin that
protrudes into a deep pocket in a neighboring subunit to mediate
dimer formation. The interaction made by the tail loop is
primarily hydrophobic in nature. A single charged residue Asp513
is found near the tip of the tail loop. The side chain of Asp513
hydrogen bonds to four main-chain nitrogens in the opposing
peptide strand from the same tail loop, thus stabilizing the
formation of the b-hairpin within the tail loop. The ISAV-NP
dimer interface is ,3520 A˚2 in size, of which a 1518 A˚2 area is
mediated by the tail loop alone. Deletion of the tail loop (DLOOP
or D504–530) resulted in the formation of NP monomers only
(Fig. 1), which suggests an important oligomerization function for
the tail loop structure in orthomyxoviruses in general.
Author Summary
Orthomyxoviruses are a family of RNA viruses that include
the various types of influenza viruses. The genome of
orthomyxoviruses consists of multiple segments of nega-
tive-sense, single-stranded RNA molecules, each packaged
in the form of rod-shaped, double-helical ribonucleopro-
tein (RNP) complexes. How different RNPs interact with
each other to ensure specific genome packaging is a long-
standing question and crucial to our understanding of
orthomyxovirus replication and influenza virus gene
reassortment. Our study of a fish orthomyxovirus, the
infectious salmon anemia virus (ISAV), shows that its
nucleoprotein (NP), which forms the protein scaffold
backbone of the viral RNP, has a bi-lobular structure like
the influenza virus NP. Because ISAV-NP forms stable
dimers in solution, we were able to determine ISAV-NP
RNA binding stoichiometry by biochemical assays, electron
microscopy and dynamic light scattering. Our results
indicate that each ISAV-NP binds ,12-nt RNA, shorter
than the 24–28 nts originally estimated for the influenza A
virus based on population average. We propose that NP-
free RNA exists on orthomyxovirus RNPs, and such RNA
regions likely mediate specific RNP-RNP interactions during
genome packaging. Further elucidation of the RNA-
mediated RNP-RNP interactions will help us determine
the molecular basis of gene reassortment by orthomyxo-
viruses including the influenza viruses.
Structure and RNA-Binding of an Orthomyxovirus NP
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The ISAV-NP RNA binding groove
Analogous to the influenza A virus NP, there is a potential
RNA-binding groove between the head and body domains of the
ISAV-NP. The groove is positively charged according to its
calculated electrostatic potentials, and is covered with a large
number of basic amino acid residues, which presumably interact
with the negatively charged phosphodiester backbone of bound
RNA (Fig. 2D, Fig. S1 – Supporting Information). All of these
basic residues, except those from the N-terminal domain, are also
found in the influenza A virus NP, although their positions may
slightly shift on the primary sequence (Fig. 2E). The aromatic
residue F274, analogous to Y148 from the influenza A virus NP
[23], is found at one end of the RNA-binding groove, and may
mediate nucleotide base stacking.
To test whether ISAV-NP binds RNA in the same manner as
the influenza A virus NP, we made two double mutants: K185A/
R186A and K296A/R299A. These two pairs of basic residues are
from two flexible loops in the potential RNA binding groove that
are partially disordered in the ISAV-NP structure. At equivalent
positions in the influenza A virus NP, R74/R75 and R174/R175
were found to play critical roles in RNA binding [24]. As expected,
mutations of these residues resulted in a dramatic decrease in the
RNA binding affinity, as the Kd changed from 24.5 nM for the
wild-type (wt) protein to 355 nM and 472 nM for the K185A/
R186A and K296A/R299A mutants, respectively (Supporting
Information, Fig. S2). This result indicates that NPs of both ISAV
and the influenza A virus likely bind RNA with their positively
charged groove.
ISAV-NP N-terminal domain and C-terminal tail
The N-terminal domain of ISAV-NP is a unique structural
feature that was not observed in the crystals structures of either the
influenza A or influenza B virus NP. Consisting of three anti-
parallel b-strands and two a-helices, the ISAV N-terminal domain
adopts an extended shape and interacts with the rest of the
structure mainly through the long a-helix made of residues 86–
112. This large a-helix partially covers the potential RNA binding
groove in between the head and body domain. Deleting the entire
N-terminal domain had little effect on the equilibrium-state RNA
binding, as wt and DN111 NP exhibited very similar RNA binding
affinities (Kd = 24.5 nM for wt vs. 33.6 nM for DN111, using a 24-
nt RNA) (Fig. 3, see the section below for more details).
Nevertheless, it is plausible that the N-terminal domain may
regulate the dynamics of the NP RNA binding. For instance, it
may help to attract RNA substrates and/or serve as a cap to
prevent the dissociation of RNA prior to being locked in a bound
position. We speculate that the long a-helix from the N-terminal
domain may need to be displaced from its current location upon
RNA binding. The inherent structural flexibility of the N-terminal
domain is evident from its high temperature factors, averaging
85.0 A˚2 for the N-terminal domain, as compared to 54.8 A˚2 for
the rest of the structure.
A multi-sequence alignment based on secondary structure
shows that a N-terminal domain is consistently found in every
orthomyxovirus NP, but it is highly variable in both size and
sequence (e.g. 21aa for influenza A virus, 72aa for influenza B
virus, and 111aa for ISAV). Furthermore, the N-terminal domain
is structurally disordered in both the influenza A and influenza B
virus NPs [23–25]. In influenza A virus, the first 20 amino acid
region contains a phosphorylation site and a nuclear localization
signal (NLS) that are important for the intracellular trafficking of
the NP [28,29]. Such functions have not been attributed to the
ISAV N-terminal domain. Although two monopartite nuclear
localization signals 230RPKR233 and 473KPKK476 have been
identified in ISAV-NP [30], both were mapped to the surface of
the body domain. The location of the N-terminal domain suggests
that it would be situated on the exterior of assembled RNPs, and
therefore may help to mediate interactions with the viral matrix
protein and/or NS2 to facilitate the intracellular trafficking of viral
RNPs.
At the C-terminal end of the ISAV-NP polypeptide is a highly
acidic C-terminal tail that was excluded from our NP construct
used for crystal structure determination (see discussions above).
The last ordered residue in the crystal structure of ISAV-NP DC16
(consisting of residues 1 to 600) is residue 586, suggesting that the
Figure 1. Gel filtration chromatograms for ISAV-NP proteins. The eluted positions of three protein standards are marked by arrows.
doi:10.1371/journal.ppat.1003624.g001
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Figure 2. ISAV-NP crystal structure. (A) Three orthogonal views of an NP dimer. One subunit is colored in green, whereas the other subunit is
colored by domains with blue for the N-terminal domain, yellow for the head, red for the body, and magenta for the tail loop. In the last panel, the
magenta tail loop is shown by space-filling model to highlight the extensive interaction mediated by the tail loop. (B) ISAV-NP (red) superimposed
onto the influenza A virus NP (cyan, PDB ID: 2IQH) [23]. (C) ISAV-NP monomer. The molecule is colored continuously from blue to red for the N-
terminus to C-terminus, respectively. Secondary structural elements are numbered. (D) Calculated electronic potential for an NP monomer. Positively
charged residues are highlighted. (B–D) are shown in the same orientation by viewing into the putative RNA binding groove, same as the middle
panel in (A). (E) ISAV-NP secondary structure assignment. a-helices are shown by cylinders and the b-strands are represented by arrows. Conserved
charged residues from the RNA binding groove are highlighted in blue. The conserved aromatic residue F274 in the groove is shown in red. The NP
sequences from ISAV and the influenza A virus were manually aligned, based on tertiary structures.
doi:10.1371/journal.ppat.1003624.g002
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entire polypeptide region after residue 586 is likely to be
disordered. We have shown that removing the last 16 residues of
the ISAV-NP resulted in an enhanced RNA binding affinity (i.e.
,6-fold increase for a 24-nt RNA) (Fig. 3A, C, see the section
below for more details). The exact functional role of the NP C-
terminal tail during virus replication remains unclear, and it is
possible that the C-terminal tail may assume a different
conformation at other functional states. For the influenza A
virus NP, the last eight residues are also negatively charged.
These last residues of the influenza A virus NP have been found
to assume three different structural conformations: (1) structur-
ally disordered [23]; (2) structurally ordered and bound to the
putative RNA binding groove [26,31]; and (3) structurally
ordered but pointing away from the RNA binding groove [24].
It was proposed that the acidic C-terminal tail of the influenza A
virus NP may function to negatively regulate NP RNA binding
activity [26,31]. Here, our finding that the ISAV-NPDC16
mutant has a stronger RNA binding affinity appears to support
this hypothesis.
ISAV-NP RNA binding
Using synthetic RNA oligos and fluorescence polarization
assays, we first measured the RNA-binding affinity of three NP
variants, wt NP, NP DN111, and NP DC16. DN111 lacks the N-
terminal domain, so its structure is comparable to that of the
influenza A virus NP. Because genome-wide stoichiometry
estimation revealed that each influenza A virus NP binds to
24 nts of RNA [19], the oligonucleotide (AC)12 (consisting of 12
AC repeats) was chosen for our initial assays. Interestingly, wt NP
and DN111 exhibited similar RNA-binding affinities (Fig. 3A and
B), suggesting that the N-terminal domain is not actively involved
in equilibrium-state RNA binding. On the other hand, NP DC16
exhibited a much stronger RNA binding affinity than wt NP,
indicating the acidic C-terminal tail negatively regulates NP-RNA
binding. When the RNA oligo was shortened from 24 nts to
20 nts, the binding affinity of NP dropped sharply with a ,10-fold
increase in Kd (Fig. 3A). On the other hand, when the size of the
RNA oligo was increased from 24 nt to 28 nt; there was little
change in NP-RNA binding affinity (Fig. 3A). Similar to the full-
Figure 3. ISAV-NP RNA binding. (A–C) RNA binding affinity measurements for the wt NP (A), DN111 (B) and DC16 (C). FA was performed using
three RNA oligos each containing 20, 24, and 28 nts. The binding curves are plotted using the same protein concentration range. For the DC16
mutant, an inset is added in (C) to provide a more spread-out view at lower protein concentrations. Fully saturated curves for the 20-nt RNA are
shown in Fig. S3 in Supporting Information. (D–G) RNA binding stoichiometry measurements for the wt NP and the DLOOP monomeric mutant.
NP:RNA complexes assembled in each experiments are schematically shown with blue handcuffs for NP dimers and grey curves for RNA molecules.
doi:10.1371/journal.ppat.1003624.g003
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length NP, RNA size has little effect on the Kd’s for binding to the
DN111 and DC16 mutants, even though the latter shows a ,10-
fold higher intrinsic affinity (Fig. 3B and C). Therefore, the 24 nt-
long RNA has saturated the NP-RNA binding site, and the small
increase in binding affinity from 24-nt to 28-nt RNA was probably
due to non-specific binding. The same trend was also observed
when DNA oligos ranging from 15 to 30 nts long were used for
binding (Supporting Information, Fig. S4).
To determine whether each 24-nt RNA binds to a single NP
subunit or to both subunits in a NP dimer, we used the same
fluorescence polarization assay to quantify binding stoichiometry.
To ensure stoichiometric binding, we adjusted the experimental
conditions such that the total concentration of RNA was
significantly above the binding dissociation constant Kd (see Online
Methods). When the wt NP was titrated in the solution, the
fraction of bound RNA, as noted from millipolarization (mP)
signal, first increased linearly and then gradually approached
saturation (Fig. 3D). Using either the inflection point extrapolation
or direct fitting of the general titration equation, we arrived at the
same conclusion that each 24-nt RNA binds to an NP dimer.
Subsequently, a similar experiment using a 48-nt RNA gave a
stoichiometry of two NP dimers per 48-nt long RNA (Fig. 3E),
consistent with our earlier result of each NP monomer binding to
,12 nts of RNA.
To rule out the possibility that one NP subunit binds 24 nts of
RNA and that RNA binding by one NP subunit allosterically
inhibits RNA binding by the other subunit in the NP dimer, a
monomeric DLOOP mutant (Fig. 1) was used for RNA binding
assays as described above. Circular dichroism spectra of the
DLOOP mutant were very similar to that of the wt NP trimer,
indicating similar overall secondary structure contents (Supporting
Information, Fig. S5). For the influenza A virus, the NP DLOOP
mutant has a tertiary structure that is nearly identical to the wt NP
except for the lacking of the tail loop [31]. A monomeric mutant
with a single amino acid substitution (i.e. R416A) in the tail loop of
the influenza A virus NP was found to undergo some structural
rearrangements in the C-terminal part of the polypeptide, but the
potential RNA binding groove remains largely intact [26].
As expected, the RNA binding affinity of the ISAV-NP DLOOP
monomer was very similar to that of the wt NP for a 12-nt long
RNA, which supposedly contains only one NP binding motif
(Kd = 488.4 nM for wt vs. 1076.1 nM for DLOOP NP). However,
the protein binding stoichiometries of the 12-nt and 24-nt RNAs
were unexpectedly different. While each 12-nt RNA bound to one
DLOOP NP monomer, each 24-nt RNA recruited two NP
DLOOP monomers when fully saturated (Fig. 3F, G). Therefore,
results obtained from the DLOOP mutant are consistent with our
earlier conclusion based on the wt NP dimer.
We then used negative-staining electron microscopy (EM) to
confirm the RNA-binding stoichiometry by measuring the number
of NP molecules associated with each RNA molecule. As shown in
Fig. 4, ISAV-NP formed dimers in the absence of RNA, with each
NP molecule assuming the shape of a 465 nm2 oval (Fig. 4A, B).
When the 24-nt RNA was added to NP at the 1:2 molar ratio (i.e.
one RNA per NP dimer), the same dimeric assemblies were
observed (Fig. 4C, D). However, when the 48 nt-RNA were added
to ISAV-NP at the 1:4 ratio (i.e. one RNA for four NP subunits),
we observed mostly tetramers, which were presumably formed by
simultaneous binding of two NP dimers to one 48-nt RNA (Fig. 4E,
F).
Similar results were also obtained from size measurement using
dynamic light scattering (DLS) (Fig. 4G). Assuming that ISAV-NP
adopts a roughly globular shape, the molecular weight of the wt
NP dimer was 150.9613.0 kD by DLS measurement. The
calculated molecular weight of a dimer is 136.5 kD, and the
slight difference could be explained by the non-globular shape of
the dimer. When the 48-nt RNA was added to the NP sample, the
molecular weight of the complex was increased to 299.7616.2 kD,
which matches closely to the calculated molecular weight of two
ISAV-NP dimers binding to a 48-nt poly(C) RNA
(26136.5+14.8 = 287.8 kD). Our results from EM and DLS once
again confirm that one ISAV-NP molecule binds to a 12-nt RNA.
Functional implication of the orthomyxovirus NP-RNA
binding
EM images of ISAV RNPs released from virions showed
double-helical structure with similar dimensions compared to
those from the influenza A viruses. For instance, it was reported
that the longest RNPs of ISAV were ,120 nm long [27], very
close to the maximum length of ,110 nm measured for the
influenza A virus RNPs [15]. ISAV contains eight gene segments,
with the longest one, which encodes PB2, containing ,2.4 kb of
nucleotides. This is only slightly larger than the longest RNA
segment of the influenza A virus, which is ,2.3 kb in length.
Therefore, considering that ISAV and the influenza A virus have
similarly sized RNPs as well as RNAs, we expect that the NP RNA
binding stoichiometry should be similar for these two viruses.
Hence, each ISAV-NP is likely associated with ,24–28 nts of
RNA in the infectious virion, as previously determined for the
influenza A viruses based on population average.
Since only the head and body domain of ISAV-NP affect
equilibrium-state RNA binding, ISAV-NP should serve as a valid
model for studying the NP-RNA binding for other orthomyxovi-
ruses including the influenza viruses. We conclude that each
ISAV-NP monomer, and possibly each influenza A virus NP, bind
,12 nts of RNA. This stoichiometry of binding is also supported
by the observation that the potential RNA-binding groove of the
ISAV and the influenza A virus NP is ,60 A˚ long. Assuming that
bound nucleotides are ,5 A˚ apart (i.e. based on single-stranded
RNAs bounds to nucleocapsids from the tobacco mosaic virus and
also rhabdoviruses), each NP molecule should bind no more than
,12 nts of RNA, consistent with our stoichiometric measure-
ments. It has also been noted by Jennings et al. that the length of
22–26 nts exceeds the dimension of NP, so RNA coiling or
looping may be necessary for RNP assembly [32]. Indeed, RNase
digestion of an influenza A virus RNPs and mini-RNPs produced
RNA fragments of ,15–18-nt in size [33,34], indicating that the
size of RNA bound by each NP should be shorter than 15–18 nts
long.
The cryo-EM reconstruction of influenza A virus RNPs shows
that NP molecules follow a regular double-helical arrangement,
with the potential RNA binding groove facing outward [17,18]. At
the current resolution, RNA densities cannot yet be identified in
the EM maps. Compared to NP dimer or longer unconstrained
NP polymers, the double-helical stem region of the RNP [17,18]
shows a wider separation between adjacent NP molecules along
the same NP strand and thus may require short RNA linkers made
of up to four extra bases. However, even with such linkers
considered, RNA would still follow a highly convoluted path if
24 nts of RNA are modeled for each NP molecule in a RNP [17].
Moreover, if we assume that the double-helical RNP is converted
from a linear NP-RNA polymer precursor during assembly, then
double-helical RNPs and linear NP-RNA polymers should have
similar NP RNA binding stoichiometry. Therefore, we believe that
the geometric difference between the helical RNP and the
unconstrained NP-RNA polymer cannot completely compensate
for the substantial difference in NP RNA stoichiometry (i.e.
,24 nts vs. ,12 nts for each NP).
Structure and RNA-Binding of an Orthomyxovirus NP
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Figure 4. ISAV-NP:RNA complexes. (A–F) EM images of the free NP (A, B), NP bound to a 24-nt RNA (C, D), and NP bound to a 48-nt RNA (E, F). (G)
Molecular weights of NP and NP:RNA complexes as determined by DLS. Molecular interpretations were made for each figure with blue handcuffs for
the NP dimers and grey curves for RNA molecules.
doi:10.1371/journal.ppat.1003624.g004
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Based on our stoichiometry measurements and the rationale as
stated above, we speculate that a fraction of the orthomyxovirus
(e.g. ISAV, influenza A viruses, etc) genomic RNA likely exists in a
NP-free state in the context of RNP. Such NP-free RNA regions
are probably rich in secondary or tertiary structures, as it has been
shown that double-stranded RNAs bind less favorably to NP
compared to single-stranded RNAs. We envision that there is an
uneven distribution of NP along the viral RNA that varies
depending on the secondary/tertiary structure of the RNA.
Because nascent v/cRNA molecules are encapsidated by NP co-
transcriptionally, we assume that only local RNA structures occur
in RNPs. Although little is known about the details of such RNA
structures, presumably they need to be stable enough to resist
denaturation by NP binding, as it has been reported that the
influenza A virus NP was able to melt the viral RNA panhandle
structure [35]. These RNA structures likely play a critical role in
the packaging of viral genome during the assembly process,
possibly by forming specific higher-order structures. These
structures would allow the eight different RNPs to recognize each
other and form the ‘‘7+1’’ array previously seen in EM images of
budding influenza A virus particles [10–13,36]. Thus, the 2-nm
thick filamentous masses connecting neighboring RNPs in
budding influenza A viruses are likely RNA structures formed by
packaging signals [13]. Because the RNA packaging signals are
usually found near both ends of the vRNA molecules [37], each
RNP may interact with at least two neighboring RNPs to build up
a network of interactions that ensure specific genome packaging.
Crystal structures of NP proteins or NP-RNA complexes have
been reported for a number of other negative-sense, single-
stranded RNA viruses including members from the rhabodovirus,
paramyxovirus, bornavirus, arenavirus and bunyavirus families
[38–53]. Among negative strand RNA viruses, rhabodovirus,
paramyxovirus, filoviru and bornavirus have a non-segmented
genome, whereas arenavirus, bunyavirus and orthomyxovirus
have a genome comprised of multiple RNA segments. For non-
segmented negative strand RNA viruses, it has been shown by
crystal structure and/or genetic evidence that their RNPs are
strictly stoichiometric complexes, with NP proteins distributed
evenly along the NP-RNA complexes; whereby vRNA is
completely unwound and protected by the NP [38–41,54,55].
For rhabodovirus, paramyxovirus, and filovirus, each of their NP
proteins binds 9, 6/7, and 6 nucleotides of RNA, respectively [39–
41,54,55]. Such properties are consistent with the function of these
RNPs, as the genomic sequences of non-segmented negative-sense
RNA viruses are not expected to mediate RNP packaging into
viral particles. Compared to NPs from non-segmented, negative-
sense RNA viruses, orthomyxovirus NPs have a different topology
and are relatively large in size. With NP-free RNA exposed on the
outer surface, the structural organization of the orthomyxovirus
RNP is optimally suited for multi-segment RNA packaging. Future
efforts in identifying RNA secondary structure will likely reveal
molecular determinants for RNP recognition and genomic RNA
reassortment for the influenza viruses and other orthomyxoviruses.
It will also be of great interest to identify molecular determinants
used by arenaviruses and bunyaviruses to facilitate specific RNP
packaging, should such a specific genome package mechanism
exist in these segmented RNA viruses as well.
Materials and Methods
1. Cloning
The full-length ISAV-NP (aa 1–616), the DC16 NP (aa 1–600),
and the DN111 NP (aa 112–616) were cloned with an N-terminal
66His tag. The polymerase chain reactions were performed using
the PfuUltraTM high-fidelity DNA polymerase (Stratagene). PCR
products were digested with NcoI and XhoI (New England
Biolabs) for 2 hours, and ligated into the pET28b+ vector for
expression in Rosetta 2 E. coli cells (DE3) (Novagen). For the ISAV
DLOOP mutant, a short linker sequence ‘‘Gly-Gly-Gly-Gly-Ser’’
was used to replace the ‘‘tail-loop’’ (aa 504–530).
2. Expression, purification, and crystallization
The expression of NP proteins was induced with 0.1 mM IPTG
at 15uC for 24 hours after the cell density had reached an
OD600 nm of 0.8. SeMet-substituted NP proteins were expressed in
M9 minimal medium supplemented with seleno-methionine
(ACROS organics). Cells were collected and sonicated in lysis
buffer containing 300 mM NaCl, 5 mM Imidazole, 10% glycerol
(v/v), and 50 mM Tris?HCl, pH 7.5. The lysate was centrifuged at
40,0006 g for 30 min and the supernatant was used for further
purification. Recombinant NP proteins were purified using a
HisTrapTM HP Column, a HiTrapTM Heparin HP Column, and
finally a SuperdexTM 200 Column (GE Healthcare). Purified
proteins were at least 95% pure according to Coomassie-stained
SDS–polyacrylamide gels. All proteins were concentrated to
10 mg/ml and stored at 4uC.
Crystals of ISAV-NP DC16 were obtained from a protein-
ssDNA complex containing the oligo dC18. Although the DNA
oligo could not be seen in the electron density, its presence was
required for crystal formation. The best DC16 crystals were grown
at 10uC for two weeks using the sitting-drop vapor diffusion
method with the drop made of equal volume of protein solution
(10 mg/ml in 200 mM NaCl, 10% glycerol, and 50 mM
Tris?HCl, pH 7.5) and well solution (containing 0.8 M lithium
chloride, 0.1 M sodium citrate, pH 4.0, and 20% PEG 6000). To
improve crystal diffraction, an additional dehydration step was
performed by transferring crystals to a mother liquor containing
0.8 M lithium chloride, 0.1 M sodium citrate, pH 4.0, 9% PEG
6000 and 20% PEG 400. After 24 hours, the crystals were directly
frozen in liquid nitrogen.
3. Data collection, phase determination, model building,
and refinement
Diffraction data were collected at the Beamline 4.2.2 at the
Advanced Light Source, Berkeley. All diffraction data were
processed using the program HKL2000 [56]. The structure was
determined by single-wavelength anomalous diffraction (SAD).
The heavy atom sites and experimental phases were determined
by the AutoSol Wizard in the PHENIX software suite [57]. The
protein model was built with Autobuild (PHENIX) and COOT
[58], and refined with phenix.refine. All the structure figures were
prepared using the program PyMOL unless otherwise specified
(The PyMOL Molecular Graphics System, Version 1.2r3pre,
Schro¨dinger, LLC). The coordinates have been deposited at the
Protein Data Bank (PDB ID 4EWC)
4. Fluorescence polarization assays
59-fluorescein-labeled RNA oligos were purchased from
Thermo Fisher Scientific and Sigma-Aldrich. The sequences of
the RNA oligos used are simple ‘‘AC’’ repeats (e.g., a 12mer RNA
has the sequence of 59–(AC)6–39) to avoid potential secondary
structures that may interfere with protein binding.
For the affinity measurements shown in Fig. 3A–C, our binding
solutions contained 100 mM NaCl, 25 mM Tris, pH 7.5, 10%
glycerol, and fluoresceinated RNA at 0.2 nM or higher (at least
10-fold lower than Kd). NPs were titrated into the binding solution
until the millipolarization (mP) stabilized. All of the experiments
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were carried out at 25uC. The data were plotted and analyzed by
using the equation P = {(Pbound2Pfree)[protein]/(Kd+[protein])}+P-
free, where P is the polarization measured at a given total protein
concentration, Pfree is the initial polarization of fluorescein-labeled
RNA without protein bound, Pbound is the maximum polarization
of RNA when all are bound by protein, and [protein] is the
protein concentration. The free and total protein concentrations
were assumed to be equal since the Kd was at least 10-fold higher
than the concentration of fluorescein-labeled RNA. The hyper-
bolic curves were fitted by nonlinear least-squares regression
analysis assuming a bimolecular model of pseudo first order such
that the Kd values represent the protein concentrations at which
half of the ligands are in the bound-state.
For the FA experiments used to determine the binding
stoichiometry, the assay conditions were identical to those used
for the binding affinity determination, except that the RNA
concentration was increased to 60 nM and the NaCl concentra-
tion was reduced to 50 mM. These adjustments were made to
ensure that the RNA concentration was at least 20-fold higher
than the Kd. The titration curves showed a linear increase (first
phase) in millipolarization until RNA-binding sites were saturated
(second phase). Data points belonging to each phase were
separately fitted by linear least-squares regression analysis to
produce the inflection point, at which point the RNAs were
stoichiometrically bound with protein.
5. Electron microscopy
The ISAV-NP DC16:48 nt-RNA sample was prepared by
mixing the protein with the 48 nt-ssRNA at a 4:1 molar ratio in
100 mM NaCl and 25 mM HEPES, pH 7.5. The DC16:24 nt-
RNA complex was prepared by mixing protein with RNA at a
molar ratio of 2:1. Both samples were incubated at 25uC for
30 min and purified by gel filtration before use.
Carbon-coated copper grids (Electron Microscopy Sciences)
were glow discharged at 5 mA for 1 min. 3 uL of protein samples
at 0.02 mg/mL was added onto glow-discharged copper grids,
washed twice with distilled water, and stained with freshly
prepared 1.5% uranyl acetate solution for 1 min. Images were
taken with a JEOL 2010 electron microscope (JEOL USA, Inc.)
operated at 100 KeV using a magnification of 40,0006.
6. Dynamic light scattering
The ISAV-NP DC16:48 nt-RNA sample was prepared in the
same manner as for EM. DLS experiments were performed using
a DynaPro99 Dynamic Light Scattering system from Wyatt. All of
the samples were centrifuged at 22,0006g for 30 min to remove
large aggregates prior to the experiments. The DLS experiments
were carried out at 25uC in 100 mM NaCl and 25 mM HEPES,
pH 7.5. For each sample, 20 molecular weight readouts were
calculated with each being the average of five individual
measurements. The 20 readouts were further averaged to obtain
the mean and standard deviation of the sample molecular weights.
Supporting Information
Figure S1 Calculated electronic potential for an ISAV-NP
monomer. Positively charged residues are highlighted. The
diagram on the left is the same as the one shown Figure 2D.
(DOCX)
Figure S2 RNA binding by wt and mutant ISAV-NP. RNA
binding affinity measurements for the wt NP and its two double
mutants, K185A/R186A and K296A/R299A, were performed by
FA using a 24-nt RNA.
(DOCX)
Figure S3 ISAV-NP RNA binding. RNA binding affinity
measurements for the wt NP, DN111 and DC16 were performed
by FA using a 20-nt RNA oligo.
(DOCX)
Figure S4 ISAV-NP DNA binding. DNA binding affinity
measurements for the wt NP were performed by FA using four
poly(C) oligos ranging from 15 to 30 nucleotides long. (A) and (B)
are plotted against a narrower and broader X-axes, respectively.
(DOCX)
Figure S5 Far-UV CD Spectra of ISAV NP. All three NP
proteins, including the wt NP (blue), DLOOP (red) and DC16
(green) were kept at 5 mM concentration. Protein buffer was
200 mM potassium phosphate pH 7.5. Measurements were done
at room temperature.
(DOCX)
Table S1 Crystallographic data statistics.
(DOCX)
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